Search

Search Constraints

You searched for: Author/Creator Tendera, Michal

Search Results

2. Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED‐HF). (March 2013)

3. Cardiopoietic stem cell therapy in ischaemic heart failure: long‐term clinical outcomes. (23rd October 2020)

4. Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study. Issue 10056 (29th October 2016)

5. Cardiovascular risk of chronic coronary syndrome patients according to vascular phenotype, diabetes, and smoking. (16th December 2020)

6. Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial. Issue 10081 (6th May 2017)

7. Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART‐1) trial design. (14th December 2015)

8. Editor's Choice – 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). (March 2018)

9. Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial. Issue 11 (November 2017)

10. Efficacy and safety of trimetazidine after percutaneous coronary intervention (ATPCI): a randomised, double-blind, placebo-controlled trial. Issue 10254 (19th September 2020)